BioSpace News Archive

Vivasure Medical today announced that the first patient was treated in a U.S. early feasibility study evaluating PerQseal.

VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, VBI’s President and CEO, will participate in an analyst-led fireside chat at the 32nd Annual Oppenheimer Healthcare Conference.

Metagenomi today announced the appointment of Christine Foster, PhD, as Chief Business Officer and Alan H. Cohen, MD, as Chief Medical Officer and Senior Vice President of Monogenic Diseases.

ALR Technologies Inc. (“ALRT” or the “Company”) (OTCQB: ALRT), the diabetes management company, today announced successful results from the conclusion of the non-inferiority study conducted on the GluCurve Pet CGM which was previously announced on February 10, 2022 and February 28, 2022.

Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel irreversible covalent small molecules to treat and improve the lives of patients with genetically defined cancers and metabolic diseases, today announced that it is scheduled to participate in a fireside chat at the Oppenheimer 32nd Annual Virtual Healthcare Conference.

TC Biopharm PLC, a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and viral indications, highlighted their intellectual property

Bearpac Medical, LLC announced that its Passio Pump Drainage System has received an Innovative Technology contract from Vizient, Inc. the nation’s largest member-driven health care performance improvement company.

The National Comprehensive Cancer Network® announced the publication of new expert consensus recommendations to address routine problems that can occur during prescribing, receiving, storing, preparing, and delivering investigational drugs.

Cerner Corporation, a global healthcare technology company, announced that its Board of Directors declared a cash dividend to stockholders of $0.27 per issued and outstanding share.

Rockwell Medical, Inc. presented survey findings in oral and poster presentations at the National Home Infusion Association’s 2022 Annual Conference, taking place March 12 through 16, 2022 in Nashville, Tennessee.